7 / 37
Definición del riesgo de NaVIQ
1. NCCN clinical practice guidelines in oncology, Antiemesis V1.2017.Available at:
http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf.2. Young A et al. Ecancermedicalscience 2013;7:296.
3. Vidall C et al. Ecancermedicalscience 2011;5:211.
4. Petrella T et al. 2009. J Support Oncol 2009;7:W9.
7